Orthokine therapy was developed by Düsseldorf orthopedic surgeon Dr. Peter Wehling and molecular biologist Dr. Julio Reinecke. Orthokine (known in the U.S. as Regenokine) is an experimental medical procedure used as an anti-inflammatory drug to reduce chronic pain and oesteoarthritis. This minimally invasive procedure has proven to be extremely effective in treating joint pain. This anti-inflammatory procedure has helped named like Kobe Bryant, Alex Rodriguez, and even members of the MMA community like Dana White, Joe Rogan, and Bas Ruten.
According to medical news today, the procedure “…is based on an understanding of the biological mechanisms that lead to of osteoarthritis and pain. In osteoarthritis, the body produces interleukin-1 (IL-1), a protein that contributes to the breakdown of cartilage. To slow down or stop this process, the biological adversary of IL-1, the interleukin-1 receptor antagonist (IL-1Ra), is used. IL-1Ra neutralizes the effect of IL 1, and has anti-inflammatory, analgesic and cartilage-protective effects. In the Orthokine method, various anti-flammatory proteins and growth factors such as IL-1Ra are obtained from the patient’s own blood and injected back into the affected joint.”
The process removes a patient’s blood from the arm and incubates it at a slighly raised temperature. The heated blood is placed in a centrifuge until its constituent parts are separated. The resulting middle, yellowish layer is dense with agents believed to stop arthritic agent interleukin-1, which causes degeneration of the joints and breakdown of cartilage. The serum is injected back into the patient’s affected area to reduce pain and discomfort in the affected joint over the course of several days, easing discomfort.
Regenokine has proven effective in helping relieve joint pain in professional athletes from many different sports. However, regenokine’s biggest hurdle in the U.S. is that is has not approved by the FDA. As such, those seeking treatment travel to Germany to receive treatment from Wehling and other practitioners. This kind of treatment could be of extreme use to those in the combat sports community. Expect to hear more athletes coming forward about the effectiveness of this treatment, especially if it does meet FDA approval.